Studies were carried out to examine the effects of dietary fat and cholesterol on cholesterol homeostasis in man. 75 12-wk studies were carried out during intake of 35% of calories as either saturated or polyunsaturated fat, first low and then high in dietary cholesterol. Dietary fat and cholesterol intakes, plasma lipid and lipoprotein levels, cholesterol absorption and sterol synthesis in isolated blood mononuclear leukocytes were measured during each diet period. In 69% of the studies the subjects compensated for the increased cholesterol intake by decreasing cholesterol fractional absorption and/or endogenous cholesterol synthesis. When an increase in plasma cholesterol levels was observed there was a failure to suppress endogenous cholesterol synthesis. Plasma cholesterol levels were more sensitive to dietary fat quality than to cholesterol quantity. The results demonstrate that the responses to dietary cholesterol and fat are highly individualized and that most individuals have effective feedback control mechanisms.
Introduction
Numerous studies, either under steady state conditions on a metabolic ward or in free-living outpatients, have demonstrated a large patient-to-patient variability in response to a dietary cholesterol challenge and to a shift in dietary fat quality . However, only in a limited number of studies have metabolic responses other than changes in plasma lipid levels been investigated: studies utilizing sterol balance techniques (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) have demonstrated that the major metabolic changes in response to a dietary cholesterol challenge are suppression of endogenous cholesterol synthesis and/or increased re-excretion of absorbed dietary cholesterol as fecal neutral steroids (2) (3) (4) (5) (6) (7) (8) (9) (10) . Some patients are able to decrease the fractional absorption of dietary cholesterol (2), or to increase bile acid synthesis and excretion (8, 9) , while others may experience an expansion of tissue stores of cholesterol (2, 5, 9) . Changes in dietary fat quality have been reported to exert no effect on whole body cholesterol metabolism (1 1, 15, 18, 20) or, in hypertriglyceridemic patients, to increase endogenous fecal neutral steroid excretion (17) . Shifting the quality of the dietary fat has been reported to alter low density lipoprotein (LDL) synthesis and/or its fractional catabolic rate (20, 36, 37) . The degree of precision in regulatory responses to a dietary cholesterol challenge in the general population remains unknown. Numerous studies in free-living outpatients suggest that a majority have relatively precise feedback control mechanisms, since an increased dietary cholesterol intake fails to significantly increase plasma cholesterol levels in the majority of subjects (3, 4, 10, (24) (25) (26) (27) (28) (29) (30) (31) . In sharp contrast to the relatively minor effect of dietary cholesterol on plasma cholesterol levels, the quality of dietary fat has been shown to have a more consistent influence on plasma lipid levels: a shift from a saturated to a mono-or polyunsaturated fat (PUFA)' diet will lower plasma cholesterol levels in the majority of subjects (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (32) (33) (34) (35) (36) (37) (38) (39) (40) . However, the extent of cholesterol lowering varies greatly from patient to patient (41) (42) (43) (44) .
Over the past five years technical developments have made it possible to study cholesterol homeostasis in free-living outpatients by a combination of three procedures: (a) refinement in measurement of dietary cholesterol intake using dietary records (45) ; (b) quantitation of the absorption of dietary cholesterol by the isotope ratio method (46) (47) (48) ; and (c) analysis of changes in the rate of endogenous cholesterol synthesis by assay of sterol synthesis rates in freshly isolated peripheral blood mononuclear leukocytes (MNL) (49) (50) (51) .
The present report describes the first application of these methods in a study designed to evaluate the effects of dietary fat quality and cholesterol quantity on both plasma lipid and lipoprotein levels and on cholesterol absorption and synthesis in a succession of 6-wk dietary periods in a population of male outpatient volunteers. A total of 75 studies were carried out in 50 individuals, comparing a low cholesterol (-250 mg/d) versus a high cholesterol (-800 mg/d) diet during intake of 35% of calories as either a PUFA (polyunsaturated to saturated fat ratio [P/S] -1.5) or saturated fat (SFA) (P/S -0.3) diet. In 25 of these volunteers, all four dietary periods were investigated. We observed a range of regulatory responses: in the majority of studies the feedback control mechanisms were sufficiently precise to compensate for a large increase in absorbed dietary cholesterol without increasing plasma cholesterol levels. In those studies where the patients exhibited a significant increase in plasma cholesterol levels upon intake of a high cholesterol diet, there was a lack ofsufficient feedback suppression ofendogenous cholesterol synthesis and thus they were unable to maintain cho-lesterol homeostasis. The results indicate that the primary determinants of a given subject's plasma cholesterol level are (a) sensitivity to dietary fat quality, and (b) the degree of precision of the feedback control responses to dietary cholesterol. These responses were highly variable from patient to patient.
Methods
Volunteers. 50 male volunteers were selected from our outpatient study population. All were asymptomatic for cardiovascular diseases and free ofsecondary causes ofhyperlipidemia. Outside ofthe dietary interventions described below, no attempts were made to alter life-style patterns, and patients were encouraged to maintain their usual habits regarding smoking, exercise, and mealtime-and work-schedules. Some key characteristics of this study group are given in Table I .
Study design. The overall study design is presented schematically in Fig. 1 . The study was described to each volunteer and informed consents were obtained after appropriate review and approval of the study by the Rockefeller University Hospital Institutional Review Board. Potential candidates were initially screened by routine physical examination which included blood and urine chemistries and hematological tests. Suitable individuals were randomized into one of the two dietary groups and instructed in the dietary guidelines (see below) on two clinic visits 1 wk apart. 4 wk after the last dietary instruction, patients attended the outpatient clinic weekly for 3 wk for analysis of cholesterol absorption, collection of dietary records, and blood sampling. At the end of week 6 each patient added three large eggs per day to his diet, and the studies were repeated on weeks 10, 11, and 12.
Those patients involved in the dietary fat exchange cross-over study (n = 25) were instructed in exchanging the quality of their dietary fat, and the entire study protocol was then repeated. No undesirable side effects or symptoms were reported throughout these studies.
Dietary instruction and evaluation. Each patient was instructed by a registered dietitian (H. Batwin) in maintaining a low cholesterol diet in which 35% of calories were to be derived from fat, either from SFA (P/ S -0.3, n = 36), which was derived primarily from dairy products, or from PUFA (P/S -1.5, n = 39), which was derived from vegetable oils and margarines. Eggs and organ meats were excluded from the diets during the low cholesterol periods. After 6 wk on the low cholesterol diet each patient was instructed to add three large eggs per day to the original diet, which would reduce calories derived from meat/fish/poultry to compensate for those added by eggs. Each patient was trained in portion-size assessment using Nasco food models and instructed in main- Cholesterol absorption measurements. Exogenous cholesterol absorption was measured during weeks S and 11 ofthe study by the plasma isotope-ratio method originally described by Zilversmit and Hughes (59) and modified by Samuel et al. (46, 47) . All doses of radiolabeled cholesterol were administered in the morning after a 14-h fasting period.
Previously reported studies have demonstrated that the coefficient of variation for the isotope-ratio measurement of exogenous cholesterol absorption in outpatients is ±6% (48) . Mass absorption of cholesterol (milligrams per day) during each dietary period was calculated in each volunteer from the known mean daily dietary cholesterol intakes obtained from the dietary records (45) and the fractional absorption ofcholesterol obtained from the plasma isotope-ratio measurements.
MNL sterol synthesis. Peripheral blood MNL were isolated according to the method of Boyum (60) Statistical analysis. Statistical analysis of differences between paired means were carried out using Student's t test (61) . Statistical significance was determined using a two-tailed statistical model. All data are presented below as means±l SD with the 95% confidence interval presented in parentheses. The data are presented in two sections: the overall results for the 75 studies in 50 volunteers studied in two dietary periods, then the results for those 25 individuals who were studied during all four dietary periods.
Results
Effect ofdietary cholesterol on plasma lipids and lipoprotein levels Dietaryfat and cholesterol intakes. We achieved the dietary goals of this study in that there were significant differences in P/S of the diets ofthe two dietary fat groups, and significant differences in dietary cholesterol intakes between the low and high cholesterol periods in the two groups (Table II) . The data indicate that both the PUFA and SFA groups exhibited a small decrease in the P/S ofthe diets when shifted from a low to a high cholesterol intake; this decrease was significant only in the PUFA group. The decrease in P/S in the PUFA group arose in part from the addition of egg fat to the diet and in part from a reduction in PUFA intake. Both diet groups increased their dietary cholesterol intake from an average of 240 mg/d to > 800 mg/d when three large eggs were added to the baseline diet. Dietary cholesterol intakes during the low cholesterol period were lowest in the PUFA group, which reflected their reduced intake of animal products. Even in the SFA group, daily cholesterol intakes were < 300 mg/d on average.
The data presented in Table II demonstrate that during the low cholesterol period the mean exogenous cholesterol absorption was 61%, and decreased to 55% during the dietary cholesterol challenge. In both groups (PUFA and SFA), these reductions in the fractional absorption of cholesterol were significant (P < 0.01). Nevertheless, in both groups the increased intakes of cholesterol resulted in significant increases in the total amount (mass) of cholesterol absorbed: a fourfold increase in the PUFA group and a 2.6-fold increase in the SFA group.
Plasma lipid and lipoprotein changes. The increased dietary cholesterol intakes failed to cause significant increases in mean levels of plasma total, LDL, or HDL cholesterol in either the PUFA or SFA groups; mean plasma triglyceride levels also remained constant throughout (Table III) . However, individual patients exhibited substantial heterogeneity in response to an increased cholesterol intake in both groups (Fig. 2) , with statistically significant increases (P < 0.05) in total plasma cholesterol observed in 8 of the 75 patients (five in the PUFA group and three in the SFA group), and significant decreases in 3 volunteers (one in PUFA and two in SFA). We found no relationship between the baseline plasma cholesterol level and sensitivity to a dietary cholesterol challenge, regardless ofthe quality ofdietary fat (Fig. 2) .
Since the plasma cholesterol response might be expected to relate to the increment in the amount of dietary cholesterol absorbed (milligrams per kilogram per day) upon moving from the low to high dietary cholesterol intake (62), we have related the percent change in plasma cholesterol to the difference in absorbed cholesterol between the low and high intake periods. Table IV demonstrates that the majority ofpatients, irrespective of the actual difference in absorbed cholesterol, were able to maintain a constant plasma cholesterol level within ±5%, the established total variability (see Methods). Ofthe 75 studies carried out, only 23 patients exhibited an increase in plasma cholesterol that was > 5%, and in only 8 was the change significant; in contrast, 8 patients actually reduced their total cholesterol levels on the higher intakes, with significant decreases occurring in 3 volunteers.
Effect ofdietary cholesterol on in vivo cholesterol metabolism Increases in absorbed dietary cholesterol were accompanied by significant reductions in MNL sterol synthesis rates (Table V) . (those exhibiting a 5% or greater increase, mean = 12%, in plasma cholesterol levels when given a dietary cholesterol challenge, n = 23). As shown in Table VI , the plasma cholesterol levels were unchanged in the compensators upon shifting from a low to high cholesterol intake, and these compensators exhibited a significant 26% reduction in MNL sterol synthesis. In contrast, the noncompensators had significant increases in plasma cholesterol levels and a nonsignificant 12% reduction in the rate of acetate incorporation into sterols in their MNL. The patient groups classified as compensators and noncompensators had similar baseline values for body weight, body mass index, percent cholesterol absorption, and MNL sterol synthesis rates. These results recall those of Nestel and Poyser (3) and Maranhao and Quintao (9) : patients who demonstrated the most effective feedback suppression of endogenous cholesterol synthesis by dietary cholesterol (as measured by sterol balance techniques) were able to maintain a constant plasma cholesterol level on a high cholesterol diet. The data presented here are consistent with the hypothesis that most individuals possess precise feedback precision of these compensatory responses to dietary factors (24-31, 37-39, 44, 66-70) .
In the present study we tested a range of intakes of dietary cholesterol from less than to slightly more than that consumed in the average American diet (7i), and variations in fat quality from levels less than that in the average American diet (P/S of 0.3 vs. 0.45) to slightly higher than that recommended (1.5 vs. In this study we have applied a series of new techniques which allow the determination of the effects of dietary fat and cholesterol on plasma lipid and lipoprotein levels, and on cholesterol absorption and endogenous synthesis, and thus are able to relate the changes in plasma lipids to metabolic responses and regulatory mechanisms.
Effects ofcholesterol quantity andfat quality on plasma cholesterol levels. The results of the 75 studies carried out in 50 patients indicate that the addition of dietary cholesterol (given as eggs) has a marginal influence on plasma lipid levels. Changes in dietary fat quality, on the other hand, had a consistent but small effect on plasma cholesterol levels: -20% of the patients intake. Open symbols Plasma Cholesterol (mg/di) PUFA Diet represent significant changes (P < 0.05). Changes in plasma cholesterol levels were significant in 7 of 25 volunteers. A similar plot for the high cholesterol diet comparison showed that plasma levels were significantly higher on the SFA diet in 6 of 25 patients. exhibited a decrease in plasma cholesterol on a high P/S fat diet, regardless of cholesterol intake. Sensitivity to dietary cholesterol varied between patients and was independent ofthe baseline plasma cholesterol level. Those patients exhibiting the greatest increase in plasma cholesterol levels were predominantly those who absorbed the largest amount of dietary cholesterol. The majority of patients were able to compensate effectively by maintaining unchanged plasma cholesterol levels. We did not observe a difference in sensitivity to dietary cholesterol in the PUFA-and SFA-fed groups, in contrast to a previous report (30) . Similar results have been reported by others (38, 72) and support the thesis that dietary fat quality and dietary cholesterol are independent in terms of changes in plasma cholesterol levels, and that fat quality has no effect on the compensatory responses to a cholesterol challenge. Neither dietary cholesterol nor the P/S of the diet altered plasma HDL cholesterol levels, presumably due to the moderate ranges of cholesterol and fat P/S used in this study.
The lack of effect of modest increases in dietary cholesterol on plasma cholesterol concentrations has been reported by a number of other investigators (24-27, 66, 68) ; in contrast, higher intakes can result in increases in plasma cholesterol levels (21, 28, 73) . The addition of 500 mg/d of dietary cholesterol to an ordinary American diet usually has little effect on plasma cholesterol levels (24-27, 30, 68, 69) ; only two studies report significant increases (29, 70).
Any evaluation of studies relating changes in dietary cholesterol to changes in plasma cholesterol must consider the following variables: (a) duration of the dietary challenge, since transient effects can occur (69); (b) degree of patient-to-patient variability in response to the challenge, since mean values do not indicate the large variability ofresponses (44, 74) ; (c) number of plasma samples obtained before and during the study, since physiological variations can be large (57) ; and (d) type of diets (formula versus solid food) fed to the study subjects. In the range of cholesterol intakes similar to the American diet, the majority of the data indicate that dietary cholesterol has a minor effect on plasma cholesterol levels in most people; however, subsets of the population exhibit sensitivity to changes in cholesterol intake (74) .
Large changes in fat P/S have consistently resulted in lowered plasma cholesterol levels (references 12-20 and many earlier reports). The modest changes tested here resulted in smaller effects: shifting from a dietary fat P/S of 0.3 to 1.8 resulted in a 5.5% mean reduction in total plasma cholesterol levels; a significant reduction in plasma cholesterol levels occurred in 7 of the 25 patients studied. Similar variability in plasma cholesterol responses to modest shifts in fat quality have been reported (39, 67, (75) (76) (77) (78) (79) . A recent report indicated that dietary beef fat (P/S 0.05) did not elevate plasma cholesterol levels as much as coconut oil (P/S 0.05), and was comparable with plasma levels on safflower oil (P/S 10.2) (79). Recent studies have also shown that intake of monounsaturated fatty acids can also be an effective cholesterol-lowering modality (40) .
The present study measured a dietary shift in P/S slightly more than that recommended to the public (64) : since the mean reduction in plasma cholesterol was only 5.5%, we would anticipate a smaller change upon moving the population's diet from P/S 0.45 to 1.0 (64) .
Effects in individual patient of cholesterol quantity andfat quality on cholesterol metabolism. The lack of a significant dietary cholesterol effect on plasma cholesterol levels in this population is due in part to two regulatory responses found in the majority of patients: (i) a small but significant reduction in the fractional absorption ofexogenous cholesterol; and (il) the feedback suppression of endogenous cholesterol synthesis. There was no relationship between the fractional absorption of dietary cholesterol and plasma LDL cholesterol levels (Fig. 5) during the low dietary cholesterol phase of the study, or during the high intake period (data not shown), as had previously been reported (80) .
Others have shown that intake of a high cholesterol diet can significantly reduce MNL 3-hydroxy-3-methylglutaryl coenzyme A reductase activity (28) and cellular LDL receptor activity (28, 81 In terms of mean changes, dietary fat quality has a consistent impact on plasma cholesterol levels, but the changes were small in moving from P/S 0.3 to 1.5. In volunteers studied during all four dietary periods the shift from a diet with a P/S of0.26 and 836 mg/d of cholesterol to a diet of P/S 1.98 and 183 mg/d of cholesterol produced a mean reduction of 8% in total plasma cholesterol. By comparing the mean changes between the four dietary periods, we estimate that the change due to the shift in P/S was 6% and to dietary cholesterol 2%. Thus, dietary fat quality has a larger and more consistent effect on plasma cholesterol than does dietary cholesterol.
The data suggest that the efficacy of changes in dietary fat and cholesterol cannot be predicted for individual patients due to the large patient-to-patient variations observed. Furthermore, our study does not provide criteria on which to separate compensators from noncompensators, short of carrying out dietary trials in individual patients. The results illustrate the importance of modifying the dietary intervention to meet the needs of the patient and that patient's responsiveness to dietary factors. As previously discussed (84), there is little evidence to justify the use of one diet to treat all hypercholesterolemic patients, and the use of other dietary alternatives, such as a high P/S diet, a monounsaturated fat diet, or even the inclusion of fish oils in the diet may be beneficial in reducing plasma cholesterol levels in some hypercholesterolemic patients. Only by detailed followup to determine the plasma cholesterol lowering efficacy of any dietary change can the most appropriate intervention for an individual patient be determined by his physician.
The long-term significance of differences between compensators and noncompensators remains to be defined. Studies by Clarkson et al. (85) on the regression ofatherosclerosis in rhesus monkeys demonstrated that animals maintained at the same plasma cholesterol levels differed in their rates of progression or regression ofatherosclerosis, depending upon whether they were compensators ("hyporesponders," in their terminology) or noncompensators ("hyperresponders"). If similar differences in lesion progression or regression exist in human beings then it becomes important to identify and intervene in hypercholesterolemic individuals who are noncompensators: these may be the individuals at highest risk for atherosclerosis and the most responsive to dietary intervention. Further studies are needed to determine the genetics of noncompensation and whether dietary interventions can effectively reduce heart disease risk in this group as compared with the relatively diet-insensitive compensators.
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